16 October 2025
16 October 2025
With a legacy rooted in global scientific excellence, Sweden is quietly building one of Europe’s most dynamic biotech ecosystems - despite lacking a big pharma anchor and facing persistent funding gaps.
A consortium led by Nordic Capital and Permira has raised its bid, though certain shareholder stances remain firm.
The funding will support the broadening of the company’s ADC platform technologies.
The organisation calls for increased focus on neurological disorders like Alzheimer’s disease, which could build on momentum set by the pharma industry.
If approved alongside current SoC maintenance therapies, Tukysa could become the first update to the regimen for HER2-positive breast cancer in over a decade.
With regard to deal volume, Houlihan Lokey topped by offering advisory services on 240 deals.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
